207 related articles for article (PubMed ID: 17259801)
1. First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group.
Colao A; Martino E; Cappabianca P; Cozzi R; Scanarini M; Ghigo E;
J Endocrinol Invest; 2006 Dec; 29(11):1017-20. PubMed ID: 17259801
[No Abstract] [Full Text] [Related]
2. Pharmacological approach to the treatment of acromegaly.
Ezzat S
Neurosurg Focus; 2004 Apr; 16(4):E3. PubMed ID: 15191332
[TBL] [Abstract][Full Text] [Related]
3. The treatment algorithm of acromegaly.
Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G
J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211
[No Abstract] [Full Text] [Related]
4. Cabergoline in acromegaly.
Kuhn E; Chanson P
Pituitary; 2017 Feb; 20(1):121-128. PubMed ID: 28025719
[TBL] [Abstract][Full Text] [Related]
5. Consensus statement: medical management of acromegaly.
Melmed S; Casanueva F; Cavagnini F; Chanson P; Frohman LA; Gaillard R; Ghigo E; Ho K; Jaquet P; Kleinberg D; Lamberts S; Laws E; Lombardi G; Sheppard MC; Thorner M; Vance ML; Wass JA; Giustina A
Eur J Endocrinol; 2005 Dec; 153(6):737-40. PubMed ID: 16322377
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of medical treatment in patients with acromegaly in clinical practice.
Lee SY; Kim JH; Lee JH; Kim YH; Cha HJ; Kim SW; Paek SH; Shin CS
Endocr J; 2018 Jan; 65(1):33-41. PubMed ID: 28931779
[TBL] [Abstract][Full Text] [Related]
7. Cabergoline treatment in acromegaly: cons.
Kasuki L; Vieira Neto L; Gadelha MR
Endocrine; 2014 Jun; 46(2):220-5. PubMed ID: 24504766
[TBL] [Abstract][Full Text] [Related]
8. Growth-hormone and prolactin excess.
Colao A; Lombardi G
Lancet; 1998 Oct; 352(9138):1455-61. PubMed ID: 9808008
[TBL] [Abstract][Full Text] [Related]
9. Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status.
Cozzi R; Attanasio R; Lodrini S; Lasio G
Clin Endocrinol (Oxf); 2004 Aug; 61(2):209-15. PubMed ID: 15272916
[TBL] [Abstract][Full Text] [Related]
10. [Acromegaly: new principles for treatment].
Jørgensen JO; Feldt-Rasmussen UF; Andersen M; Kristensen LØ; Laurberg P; Weeke J
Ugeskr Laeger; 2007 Mar; 169(10):904-6. PubMed ID: 17359733
[TBL] [Abstract][Full Text] [Related]
11. Cabergoline in the treatment of acromegaly: a study in 64 patients.
Abs R; Verhelst J; Maiter D; Van Acker K; Nobels F; Coolens JL; Mahler C; Beckers A
J Clin Endocrinol Metab; 1998 Feb; 83(2):374-8. PubMed ID: 9467544
[TBL] [Abstract][Full Text] [Related]
12. Cabergoline treatment in acromegaly: pros.
Marazuela M; Ramos-Leví A; Sampedro-Núñez M; Bernabeu I
Endocrine; 2014 Jun; 46(2):215-9. PubMed ID: 24532103
[TBL] [Abstract][Full Text] [Related]
13. [Optimization of the medical treatment for acromegaly].
Díez JJ; Iglesias P
Med Clin (Barc); 2013 Apr; 140(8):360-5. PubMed ID: 23103101
[TBL] [Abstract][Full Text] [Related]
14. New medical therapies of acromegaly.
Maffezzoni F; Frara S; Doga M; Mazziotti G; Giustina A
Growth Horm IGF Res; 2016; 30-31():58-63. PubMed ID: 27745780
[TBL] [Abstract][Full Text] [Related]
15. [Therapeutic management of acromegaly].
Metzner C; Hadziselimovic S; Grafe I; Nawroth P; Kasperk C
Med Klin (Munich); 2006 Jan; 101(1):15-23. PubMed ID: 16418810
[TBL] [Abstract][Full Text] [Related]
16. Current pharmacotherapy for acromegaly: a review.
Biermasz NR; Romijn JA; Pereira AM; Roelfsema F
Expert Opin Pharmacother; 2005 Nov; 6(14):2393-405. PubMed ID: 16259571
[TBL] [Abstract][Full Text] [Related]
17. French consensus on the management of acromegaly.
Chanson P; Bertherat J; Beckers A; Bihan H; Brue T; Caron P; Chabre O; Cogne M; Cortet-Rudelli C; Delemer B; Dufour H; Gaillard R; Gueydan M; Morange I; Souberbielle JC; Tabarin A; ;
Ann Endocrinol (Paris); 2009 Apr; 70(2):92-106. PubMed ID: 19345931
[No Abstract] [Full Text] [Related]
18. Use of lanreotide in combination with cabergoline or pegvisomant in patients with acromegaly in the clinical practice: The ACROCOMB study.
Puig-Domingo M; Soto A; Venegas E; Vilchez R; Blanco C; Cordido F; Lucas T; Marazuela M; Casany R; Cuatrecasas G; Fajardo C; Gálvez MÁ; Maraver S; Martín T; Romero E; Paja M; Picó A; Bernabeu I; Resmini E;
Endocrinol Nutr; 2016 Oct; 63(8):397-408. PubMed ID: 27448708
[TBL] [Abstract][Full Text] [Related]
19. Current management of acromegaly.
Díez JJ; Iglesias P
Expert Opin Pharmacother; 2000 Jul; 1(5):991-1006. PubMed ID: 11249504
[TBL] [Abstract][Full Text] [Related]
20. [Novel pharmacologic therapies in acromegaly].
Góth M; Hubina E; Kovács L; Szabolcs I
Orv Hetil; 2002 May; 143(19 Suppl):1057-62. PubMed ID: 12063860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
